FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

The Guardian - World NewsCenter-LeftEN 5 min read 100% complete by Melody SchreiberFebruary 13, 2026 at 12:00 PM
FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

AI Summary

long article 5 min

The US Food and Drug Administration (FDA) has refused to consider Moderna's application for a new flu vaccine based on messenger RNA (mRNA) technology. The decision was made after a senior FDA official described the clinical trial as a "brazen failure" due to design issues, including a control group that did not receive the best-available standard of care in the US at the time of the study. Experts claim this is part of an "anti-vaccine agenda", citing concerns over the rejection of mRNA vaccines and other conventional science. The decision has been criticized by experts, who argue that the FDA's communication on the issue raises alarm and appears to be politically motivated. Moderna says the FDA frequently weighed in on its application during development. The rejection is seen as having a chilling effect on vaccine development.

Keywords

fda rejection 90% anti-vaccine agenda 80% mrna vaccine 80% vaccine efficacy 70% flu shot 70% vaccine development 60% clinical trial design 50%

Sentiment Analysis

Very Negative
Score: -0.60

Source Transparency

Source
The Guardian - World News
Political Lean
Center-Left (-0.40)
Far LeftCenterFar Right
Classification Confidence
90%

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.
Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.